Results 121 to 130 of about 65,145,522 (276)

The clinical features of patients with severe fever with thrombocytopenia syndrome between survivors and non-survivors.

open access: yes
The clinical features of patients with severe fever with thrombocytopenia syndrome between survivors and non-survivors.
Shaoqiu Zhang (18325980)   +13 more
core   +1 more source

New Insights Into Pathogenesis, Diagnostics, and Therapeutic Options for Canine Angiostrongylosis

open access: yesJournal of Veterinary Emergency and Critical Care, EarlyView.
ABSTRACT Objective To provide a comprehensive overview of Angiostrongylus vasorum infection in dogs, with a particular emphasis on recent developments in the understanding of disease pathophysiology and an update on developments in diagnostic and therapeutic options.
Iris Elgueta   +3 more
wiley   +1 more source

SFTS exerts an underrecognized disease burden and socioeconomic effect in East Asia

open access: yesBiosafety and Health
Severe fever with thrombocytopenia syndrome virus (SFTSV) is an emerging tick-borne virus that poses a growing public health concern, especially in East Asia.
Wen Zheng   +7 more
doaj   +1 more source

Causes and Outcome of Systemic Inflammatory Response Syndrome in Dogs: An Observational Study of 172 Cases

open access: yesJournal of Veterinary Emergency and Critical Care, EarlyView.
ABSTRACT Objective To evaluate the clinical characteristics, underlying diseases, organ dysfunctions, and survival of dogs with systemic inflammatory response syndrome (SIRS) or sepsis. Design Prospective observational study from January to December, 2023. Setting Single‐center, veterinary university teaching hospital.
Myriam A. Knopf   +10 more
wiley   +1 more source

Clinical characteristics of 48 case-patients with severe fever with thrombocytopenia syndrome at admission grouped according to outcome in Japan.

open access: yes, 2016
Clinical characteristics of 48 case-patients with severe fever with thrombocytopenia syndrome at admission grouped according to outcome in Japan.
Hirofumi Kato (2726779)   +6 more
core   +1 more source

Aumolertinib Versus Osimertinib as First‐Line Treatment for EGFR‐Mutant Non‐Small Cell Lung Cancer: A Retrospective Real‐World Multicenter Study

open access: yesInternational Journal of Cancer, Volume 159, Issue 10, Page 2575-2584, 15 November 2026.
As third‐generation EGFR‐tyrosine kinase inhibitors, both aumolertinib and osimertinib demonstrate clinical efficacy for non‐small cell lung adenocarcinoma, especially in patients with brain metastases. Currently, head‐to‐head studies comparing these two agents in real‐world settings are scarce.
Jinxia Wang   +9 more
wiley   +1 more source

A prediction model to discriminate severe fever with thrombocytopenia syndrome with hemorrhagic fever with renal syndrome

open access: yesAnnals of Medicine
Background The Bunyavirales order encompasses hantavirus and severe fever with thrombocytopenia syndrome virus (SFTSV), which could cause hemorrhagic fever with renal syndrome (HFRS) and severe fever with thrombocytopenia syndrome (SFTS), respectively ...
Xiaoyu Xue   +7 more
doaj   +1 more source

Laboratory findings of 48 case-patients with severe fever with thrombocytopenia syndrome at admission grouped according to outcome in Japan.

open access: yes, 2016
Laboratory findings of 48 case-patients with severe fever with thrombocytopenia syndrome at admission grouped according to outcome in Japan.
Hirofumi Kato (2726779)   +6 more
core   +1 more source

Patient Journey, Disease Burden, Treatment Patterns, and the Impact of Delayed Diagnosis Among Patients With Sjögren's Disease: A Real‐World US Survey

open access: yesACR Open Rheumatology, Volume 8, Issue 10, October 2026.
Objective The aim of this study was to investigate disease burden, treatment patterns, and impact of delayed diagnosis on patient outcomes in Sjögren's disease (SjD) in a real‐world setting in the United States. Methods Data were drawn from the Adelphi Primary Sjögren's Syndrome Disease Specific Programme, a US‐based cross‐sectional collaborative ...
Anjana Lalla   +4 more
wiley   +1 more source

Evaluating the Efficacy of Cytokine‐Directed Therapies in the Management of VEXAS Syndrome

open access: yesACR Open Rheumatology, Volume 8, Issue 10, October 2026.
Objective To evaluate the efficacy of cytokine‐directed therapies in VEXAS (vacuoles, E1 enzyme, X‐linked, autoinflammatory somatic) syndrome using previously proposed treatment response criteria. Methods All patients with genetically confirmed VEXAS syndrome who received targeted therapies with JAK inhibitors (JAKi), tumor necrosis factor α inhibitors
Daniel Montes   +15 more
wiley   +1 more source

Home - About - Disclaimer - Privacy